Saline Breast Implant Makers Must Submit PMAs By Nov. 17, FDA Says
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers of saline breast implants have until Nov. 17 to file either a premarket approval application, product development protocol or an investigational device exemption for their products or remove them from commercial distribution, FDA says in an Aug. 19 final rule.
You may also be interested in...
FDA, Congress Examine Saline Implant Data; Silicone PMA Expected In 2002
Mentor and Inamed should reconvene focus groups to review patient labeling changes for saline-filled breast implants, FDA's General and Plastic Surgery Devices Panel recommended July 9 at its meeting in Gaithersburg, Maryland
FDA, Congress Examine Saline Implant Data; Silicone PMA Expected In 2002
Mentor and Inamed should reconvene focus groups to review patient labeling changes for saline-filled breast implants, FDA's General and Plastic Surgery Devices Panel recommended July 9 at its meeting in Gaithersburg, Maryland
PIP Saline Implant Deemed "Not Approvable" Due To Paucity Of Data
Poly Implants Prostheses' premarket approval application for a prefilled saline breast implant included clinical data on only 6.4% of the number of patients deemed necessary by FDA for approval, the agency's General and Plastic Surgery Devices panel determined March 2.